Keywords
Last Name
Institution

BRIAN EDWARD GILBERT

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Molecular Virology & Microbiology
DivisionMolecular Virology & Microbiology
AddressOne Baylor Plaza
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Liang D, Tian L, You R, Halpert MM, Konduri V, Baig YC, Paust S, Kim D, Kim S, Jia F, Huang S, Zhang X, Kheradmand F, Corry DB, Gilbert BE, Levitt JM, Decker WK. AIMp1 Potentiates TH1 Polarization and Is Critical for Effective Antitumor and Antiviral Immunity. Front Immunol. 2017; 8:1801. PMID: 29379495.
      View in: PubMed
    2. Koire A, Gilbert BE, Sucgang R, Zechiedrich L. Correction: Repurposed Transcriptomic Data Reveal Small Viral RNA Produced by Influenza Virus during Infection in Mice. PLoS One. 2017; 12(12):e0189384. PMID: 29206873.
      View in: PubMed
    3. Hong MJ, Gu BH, Madison MC, Landers C, Tung HY, Kim M, Yuan X, You R, Machado AA, Gilbert BE, Soroosh P, Elloso M, Song L, Chen M, Corry DB, Diehl G, Kheradmand F. Protective role of ?d T cells in cigarette smoke and influenza infection. Mucosal Immunol. 2017 Nov 01. PMID: 29091081.
      View in: PubMed
    4. Leiva-Juarez MM, Kirkpatrick CT, Gilbert BE, Scott B, Tuvim MJ, Dickey BF, Evans SE, Markesich D. Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir. Eur J Pharmacol. 2018 Jan 05; 818:191-197. PMID: 29066417.
      View in: PubMed
    5. Stobart CC, Rostad CA, Ke Z, Dillard RS, Hampton CM, Strauss JD, Yi H, Hotard AL, Meng J, Pickles RJ, Sakamoto K, Lee S, Currier MG, Moin SM, Graham BS, Boukhvalova MS, Gilbert BE, Blanco JC, Piedra PA, Wright ER, Moore ML. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Nat Commun. 2016 Dec 21; 7:13916. PMID: 28000669.
      View in: PubMed
    6. Koire A, Gilbert BE, Sucgang R, Zechiedrich L. Repurposed Transcriptomic Data Reveal Small Viral RNA Produced by Influenza Virus during Infection in Mice. PLoS One. 2016; 11(10):e0165729. PMID: 27788253.
      View in: PubMed
    7. Lam T, Harmancey R, Vasquez H, Gilbert B, Patel N, Hariharan V, Lee A, Covey M, Taegtmeyer H. Reversal of intramyocellular lipid accumulation by lipophagy and a p62-mediated pathway. Cell Death Discov. 2016; 2:16061. PMID: 27625792; PMCID: PMC4993124.
    8. Rostad CA, Stobart CC, Gilbert BE, Pickles RJ, Hotard AL, Meng J, Blanco JC, Moin SM, Graham BS, Piedra PA, Moore ML. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats. J Virol. 2016 Aug 15; 90(16):7508-18. PMID: 27279612.
      View in: PubMed
    9. Perron M, Stray K, Kinkade A, Theodore D, Lee G, Eisenberg E, Sangi M, Gilbert BE, Jordan R, Piedra PA, Toms GL, Mackman R, Cihlar T. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process. Antimicrob Agents Chemother. 2016 Mar; 60(3):1264-73. PMID: 26666922; PMCID: PMC4776015 [Available on 09/01/16].
    10. Detalle L, Stohr T, Palomo C, Piedra PA, Gilbert BE, Mas V, Millar A, Power UF, Stortelers C, Allosery K, Melero JA, Depla E. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2015; 60(1):6-13. PMID: 26438495.
      View in: PubMed
    11. Evans CW, Atkins C, Pathak A, Gilbert BE, Noah JW. Benzimidazole analogs inhibit respiratory syncytial virus G protein function. Antiviral Res. 2015 Sep; 121:31-8. PMID: 26116756.
      View in: PubMed
    12. Kim E, Okada K, Beeler JA, Crim RL, Steitz J, Piedra PA, Gilbert BE, Gambotto A. Correction for Kim et al., development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model. J Virol. 2015 May; 89(9):5193. PMID: 25841050; PMCID: PMC4403469.
    13. Mackman RL, Sangi M, Sperandio D, Parrish JP, Eisenberg E, Perron M, Hui H, Zhang L, Siegel D, Yang H, Saunders O, Boojamra C, Lee G, Samuel D, Babaoglu K, Carey A, Gilbert BE, Piedra PA, Strickley R, Iwata Q, Hayes J, Stray K, Kinkade A, Theodore D, Jordan R, Desai M, Cihlar T. Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study. J Med Chem. 2015 Feb 26; 58(4):1630-43. PMID: 25574686.
      View in: PubMed
    14. De Groote P, Tran HT, Fransen M, Tanghe G, Urwyler C, De Craene B, Leurs K, Gilbert B, Van Imschoot G, De Rycke R, Guérin CJ, Holland P, Berx G, Vandenabeele P, Lippens S, Vleminckx K, Declercq W. A novel RIPK4-IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromes. Cell Death Differ. 2015 Jun; 22(6):1012-24. PMID: 25430793.
      View in: PubMed
    15. Schepens B, Sedeyn K, Vande Ginste L, De Baets S, Schotsaert M, Roose K, Houspie L, Van Ranst M, Gilbert B, van Rooijen N, Fiers W, Piedra P, Saelens X. Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein. EMBO Mol Med. 2014 Nov; 6(11):1436-54. PMID: 25298406; PMCID: PMC4237470.
    16. Ressler SJ, Dang TD, Wu SM, Tse DY, Gilbert BE, Vyakarnam A, Yang F, Schauer IG, Barron DA, Rowley DR. WFDC1 is a key modulator of inflammatory and wound repair responses. Am J Pathol. 2014 Nov; 184(11):2951-64. PMID: 25219356; PMCID: PMC4215025.
    17. Chen M, Hong MJ, Sun H, Wang L, Shi X, Gilbert BE, Corry DB, Kheradmand F, Wang J. Essential role for autophagy in the maintenance of immunological memory against influenza infection. Nat Med. 2014 May; 20(5):503-10. PMID: 24747745; PMCID: PMC4066663.
    18. Hiatt A, Bohorova N, Bohorov O, Goodman C, Kim D, Pauly MH, Velasco J, Whaley KJ, Piedra PA, Gilbert BE, Zeitlin L. Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):5992-7. PMID: 24711420; PMCID: PMC4000855.
    19. Kim E, Okada K, Beeler JA, Crim RL, Piedra PA, Gilbert BE, Gambotto A. Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model. J Virol. 2014 May; 88(9):5100-8. PMID: 24574396; PMCID: PMC3993798.
    20. Chang JH, Hu H, Jin J, Puebla-Osorio N, Xiao Y, Gilbert BE, Brink R, Ullrich SE, Sun SC. TRAF3 regulates the effector function of regulatory T cells and humoral immune responses. J Exp Med. 2014 Jan 13; 211(1):137-51. PMID: 24378539; PMCID: PMC3892978.
    21. Konduri V, Decker WK, Halpert MM, Gilbert B, Safdar A. Modeling dendritic cell vaccination for influenza prophylaxis: potential applications for niche populations. J Infect Dis. 2013 Jun 1; 207(11):1764-72. PMID: 23460750.
      View in: PubMed
    22. Zeitlin L, Bohorov O, Bohorova N, Hiatt A, Kim do H, Pauly MH, Velasco J, Whaley KJ, Barnard DL, Bates JT, Crowe JE, Piedra PA, Gilbert BE. Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs. 2013 Mar-Apr; 5(2):263-9. PMID: 23396091; PMCID: PMC3893236.
    23. Tuvim MJ, Gilbert BE, Dickey BF, Evans SE. Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia. PLoS One. 2012; 7(1):e30596. PMID: 22299046; PMCID: PMC3267724.
    24. Catanese DJ, Fogg JM, Schrock DE, Gilbert BE, Zechiedrich L. Supercoiled Minivector DNA resists shear forces associated with gene therapy delivery. Gene Ther. 2012 Jan; 19(1):94-100. PMID: 21633394; PMCID: PMC3252587.
    25. Tai W, Roberts L, Seryshev A, Gubatan JM, Bland CS, Zabriskie R, Kulkarni S, Soong L, Mbawuike I, Gilbert B, Kheradmand F, Corry DB. Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic. Mucosal Immunol. 2011 Mar; 4(2):197-207. PMID: 20736998.
      View in: PubMed
    26. Latimer P, Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Exp Biol Med (Maywood). 2009 Oct; 234(10):1244-52. PMID: 19657067.
      View in: PubMed
    27. Woo JK, Choi DS, Tran HT, Gilbert BE, Hong WK, Lee HY. Liposomal encapsulation of deguelin: evidence for enhanced antitumor activity in tobacco carcinogen-induced and oncogenic K-ras-induced lung tumorigenesis. Cancer Prev Res (Phila). 2009 Apr; 2(4):361-9. PMID: 19336726; PMCID: PMC2743316.
    28. Tuvim MJ, Evans SE, Clement CG, Dickey BF, Gilbert BE. Augmented lung inflammation protects against influenza A pneumonia. PLoS One. 2009; 4(1):e4176. PMID: 19137067; PMCID: PMC2613561.
    29. Gilbert BE, McLeay MT. MegaRibavirin aerosol for the treatment of influenza A virus infections in mice. Antiviral Res. 2008 Jun; 78(3):223-9. PMID: 18281104; PMCID: PMC2405943.
    30. Wyde PR, Laquerre S, Chetty SN, Gilbert BE, Nitz TJ, Pevear DC. Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol. Antiviral Res. 2005 Oct; 68(1):18-26. PMID: 16112208.
      View in: PubMed
    31. Zakharian TY, Seryshev A, Sitharaman B, Gilbert BE, Knight V, Wilson LJ. A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture. J Am Chem Soc. 2005 Sep 14; 127(36):12508-9. PMID: 16144396.
      View in: PubMed
    32. Lawson KA, Anderson K, Snyder RM, Simmons-Menchaca M, Atkinson J, Sun LZ, Bandyopadhyay A, Knight V, Gilbert BE, Sanders BG, Kline K. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis. Cancer Chemother Pharmacol. 2004 Nov; 54(5):421-31. PMID: 15197487.
      View in: PubMed
    33. Verschraegen CF, Gilbert BE, Loyer E, Huaringa A, Walsh G, Newman RA, Knight V. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res. 2004 Apr 1; 10(7):2319-26. PMID: 15073107.
      View in: PubMed
    34. Koshkina NV, Golunski E, Roberts LE, Gilbert BE, Knight V. Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. J Aerosol Med. 2004; 17(1):7-14. PMID: 15120008.
      View in: PubMed
    35. Knight V, Koshkina NV, Golunski E, Roberts LE, Gilbert BE. Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. Trans Am Clin Climatol Assoc. 2004; 115:395-404; discussion 404. PMID: 17060982; PMCID: PMC2263789.
    36. Wyde PR, Chetty SN, Timmerman P, Gilbert BE, Andries K. Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection. Antiviral Res. 2003 Nov; 60(3):221-31. PMID: 14638398.
      View in: PubMed
    37. Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Knight V, Gilbert BE, Conti C, Sanders BG, Kline K. Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther. 2003 May; 2(5):437-44. PMID: 12748305.
      View in: PubMed
    38. Lee HY, Suh YA, Lee JI, Hassan KA, Mao L, Force T, Gilbert BE, Jacks T, Kurie JM. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer. Clin Cancer Res. 2002 Sep; 8(9):2970-5. PMID: 12231543.
      View in: PubMed
    39. Gautam A, Waldrep JC, Densmore CL, Koshkina N, Melton S, Roberts L, Gilbert B, Knight V. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin. Gene Ther. 2002 Mar; 9(5):353-7. PMID: 11938455.
      View in: PubMed
    40. Gilbert BE, Seryshev A, Knight V, Brayton C. 9-nitrocamptothecin liposome aerosol: lack of subacute toxicity in dogs. Inhal Toxicol. 2002 Feb; 14(2):185-97. PMID: 12122579.
      View in: PubMed
    41. Koshkina NV, Knight V, Gilbert BE, Golunski E, Roberts L, Waldrep JC. Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO2-enriched air: pharmacokinetic studies. Cancer Chemother Pharmacol. 2001 May; 47(5):451-6. PMID: 11391862.
      View in: PubMed
    42. Wyde PR, Stittelaar KJ, Osterhaus AD, Guzman E, Gilbert BE. Use of cotton rats for preclinical evaluation of measles vaccines. Vaccine. 2000 Aug 15; 19(1):42-53. PMID: 10924785.
      View in: PubMed
    43. Koshkina NV, Kleinerman ES, Waidrep C, Jia SF, Worth LL, Gilbert BE, Knight V. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin Cancer Res. 2000 Jul; 6(7):2876-80. PMID: 10914737.
      View in: PubMed
    44. Wyde PR, Moore-Poveda DK, De Clercq E, Neyts J, Matsuda A, Minakawa N, Guzman E, Gilbert BE. Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections. Antimicrob Agents Chemother. 2000 May; 44(5):1146-52. PMID: 10770743; PMCID: PMC89836.
    45. Verschraegen CF, Jaeckle K, Giovanella B, Knight V, Gilbert BE. Alternative administration of camptothecin analogues. Ann N Y Acad Sci. 2000; 922:237-46. PMID: 11193899.
      View in: PubMed
    46. Verschraegen CF, Gilbert BE, Huaringa AJ, Newman R, Harris N, Leyva FJ, Keus L, Campbell K, Nelson-Taylor T, Knight V. Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs. Ann N Y Acad Sci. 2000; 922:352-4. PMID: 11193921.
      View in: PubMed
    47. Knight V, Kleinerman ES, Waldrep JC, Giovanella BC, Gilbert BE, Koshkina NV. 9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice. Ann N Y Acad Sci. 2000; 922:151-63. PMID: 11193890.
      View in: PubMed
    48. Knight V, Koshkina N, Waldrep C, Giovanella BC, Kleinerman E, Gilbert B. Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice. Trans Am Clin Climatol Assoc. 2000; 111:135-45. PMID: 10881338; PMCID: PMC2194367.
    49. Letsou GV, Safi HJ, Reardon MJ, Ergenoglu M, Li Z, Klonaris CN, Baldwin JC, Gilbert BE, Waldrep JC. Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression. Ann Thorac Surg. 1999 Dec; 68(6):2044-8. PMID: 10616974.
      View in: PubMed
    50. Parthasarathy R, Gilbert B, Mehta K. Aerosol delivery of liposomal all-trans-retinoic acid to the lungs. Cancer Chemother Pharmacol. 1999; 43(4):277-83. PMID: 10071977.
      View in: PubMed
    51. Koshkina NV, Gilbert BE, Waldrep JC, Seryshev A, Knight V. Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice. Cancer Chemother Pharmacol. 1999; 44(3):187-92. PMID: 10453719.
      View in: PubMed
    52. Knight V, Koshkina NV, Waldrep JC, Giovanella BC, Gilbert BE. Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice. Cancer Chemother Pharmacol. 1999; 44(3):177-86. PMID: 10453718.
      View in: PubMed
    53. Wyde PR, Moore-Poveda DK, O'Hara B, Ding WD, Mitsner B, Gilbert BE. CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats. Antiviral Res. 1998 Apr; 38(1):31-42. PMID: 9614002.
      View in: PubMed
    54. Gilbert BE, Knight C, Alvarez FG, Waldrep C, Rodarte JR, Knight V, Eschenbacher WL. Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol. Am J Respir Crit Care Med. 1997 Dec; 156(6):1789-93. PMID: 9412556.
      View in: PubMed
    55. Waldrep JC, Gilbert BE, Knight CM, Black MB, Scherer PW, Knight V, Eschenbacher W. Pulmonary delivery of beclomethasone liposome aerosol in volunteers. Tolerance and safety. Chest. 1997 Feb; 111(2):316-23. PMID: 9041975.
      View in: PubMed
    56. Mbawuike IN, Acuna C, Caballero D, Pham-Nguyen K, Gilbert B, Petribon P, Harmon M. Reversal of age-related deficient influenza virus-specific CTL responses and IFN-gamma production by monophosphoryl lipid A. Cell Immunol. 1996 Oct 10; 173(1):64-78. PMID: 8871602.
      View in: PubMed
    57. Wyde PR, Moore DK, Pimentel DM, Gilbert BE, Nimrod R, Panet A. Recombinant superoxide dismutase (SOD) administered by aerosol inhibits respiratory syncytial virus infection in cotton rats. Antiviral Res. 1996 Jul; 31(3):173-84. PMID: 8811202.
      View in: PubMed
    58. Gilbert BE. Liposomal aerosols in the management of pulmonary infections. J Aerosol Med. 1996; 9(1):111-22. PMID: 10160201.
      View in: PubMed
    59. Katkin JP, Gilbert BE, Langston C, French K, Beaudet AL. Aerosol delivery of a beta-galactosidase adenoviral vector to the lungs of rodents. Hum Gene Ther. 1995 Aug; 6(8):985-95. PMID: 7578420.
      View in: PubMed
    60. Englund JA, Piedra PA, Ahn YM, Gilbert BE, Hiatt P. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr. 1994 Oct; 125(4):635-41. PMID: 7931890.
      View in: PubMed
    61. Gilbert BE, Wyde PR, Lopez-Berestein G, Wilson SZ. Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice. Antimicrob Agents Chemother. 1994 Feb; 38(2):356-9. PMID: 8192464; PMCID: PMC284455.
    62. Gilbert BE, Wilson SZ, Garcon NM, Wyde PR, Knight V. Characterization and administration of cyclosporine liposomes as a small-particle aerosol. Transplantation. 1993 Oct; 56(4):974-7. PMID: 8212222.
      View in: PubMed
    63. Gilbert BE, Wyde PR, Wilson SZ, Meyerson LR. SP-303 small-particle aerosol treatment of influenza A virus infection in mice and respiratory syncytial virus infection in cotton rats. Antiviral Res. 1993 May; 21(1):37-45. PMID: 8317921.
      View in: PubMed
    64. Wyde PR, Ambrose MW, Meyerson LR, Gilbert BE. The antiviral activity of SP-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats. Antiviral Res. 1993 Feb; 20(2):145-54. PMID: 8384824.
      View in: PubMed
    65. Wyde PR, Ambrose MW, Voss TG, Meyer HL, Gilbert BE. Measles virus replication in lungs of hispid cotton rats after intranasal inoculation. Proc Soc Exp Biol Med. 1992 Oct; 201(1):80-7. PMID: 1528912.
      View in: PubMed
    66. Gilbert BE, Wyde PR, Wilson SZ. Aerosolized liposomal amphotericin B for treatment of pulmonary and systemic Cryptococcus neoformans infections in mice. Antimicrob Agents Chemother. 1992 Jul; 36(7):1466-71. PMID: 1510442; PMCID: PMC191605.
    67. Gilbert BE, Wyde PR, Ambrose MW, Wilson SZ, Knight V. Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory syncytial virus infection in cotton rats. Antiviral Res. 1992 Jan; 17(1):33-42. PMID: 1736809.
      View in: PubMed
    68. Gilbert BE, Wyde PR, Wilson SZ, Robins RK. Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus. Antimicrob Agents Chemother. 1991 Jul; 35(7):1448-53. PMID: 1929307; PMCID: PMC245188.
    69. Knight V, Gilbert BE, Wyde PR, Englund JA. High dose-short duration ribavirin aerosol treatment--a review. Bull Int Union Tuberc Lung Dis. 1991 Jun-Sep; 66(2-3):97-101. PMID: 1756300.
      View in: PubMed
    70. Wyde PR, Ambrose MW, Meyer HL, Zolinski CL, Gilbert BE. Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats. Antiviral Res. 1990 Oct-Nov; 14(4-5):215-25. PMID: 1965109.
      View in: PubMed
    71. Wyde PR, Ambrose MW, Meyer HL, Gilbert BE. Toxicity and antiviral activity of LY253963 against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats. Antiviral Res. 1990 Oct-Nov; 14(4-5):237-47. PMID: 1965110.
      View in: PubMed
    72. Englund JA, Piedra PA, Jefferson LS, Wilson SZ, Taber LH, Gilbert BE. High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection. J Pediatr. 1990 Aug; 117(2 Pt 1):313-20. PMID: 2380833.
      View in: PubMed
    73. Knight V, Gilbert BE. Aerosol treatment of respiratory viral disease. Lung. 1990; 168 Suppl:406-13. PMID: 2117142.
      View in: PubMed
    74. Garcon NM, Six HR, Frazer J, Hazlewood C, Gilbert BE, Knight V. Liposomes of enviroxime and phosphatidylcholine: definition of the drug-phospholipid interactions. Antiviral Res. 1989 Mar; 11(2):89-98. PMID: 2729956.
      View in: PubMed
    75. Wyde PR, Gilbert BE, Ambrose MW. Comparison of the anti-respiratory syncytial virus activity and toxicity of papaverine hydrochloride and pyrazofurin in vitro and in vivo. Antiviral Res. 1989 Feb; 11(1):15-26. PMID: 2653219.
      View in: PubMed
    76. Knight V, Gilbert B. Antiviral therapy with small particle aerosols. Eur J Clin Microbiol Infect Dis. 1988 Dec; 7(6):721-31. PMID: 2850911.
      View in: PubMed
    77. Gilbert BE, Six HR, Wilson SZ, Wyde PR, Knight V. Small particle aerosols of enviroxime-containing liposomes. Antiviral Res. 1988 Sep; 9(6):355-65. PMID: 3228281.
      View in: PubMed
    78. Knight V, Yu CP, Gilbert BE, Divine GW. Estimating the dosage of ribavirin aerosol according to age and other variables. J Infect Dis. 1988 Aug; 158(2):443-8. PMID: 3403994.
      View in: PubMed
    79. Wyde PR, Six HR, Wilson SZ, Gilbert BE, Knight V. Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes. Antimicrob Agents Chemother. 1988 Jun; 32(6):890-5. PMID: 2843086; PMCID: PMC172302.
    80. Gilbert BE, Wyde PR. Pharmacokinetics of ribavirin aerosol in mice. Antimicrob Agents Chemother. 1988 Jan; 32(1):117-21. PMID: 3348604; PMCID: PMC172109.
    81. Knight V, Gilbert BE. Ribavirin aerosol treatment of influenza. Infect Dis Clin North Am. 1987 Jun; 1(2):441-57. PMID: 3332797.
      View in: PubMed
    82. Wyde PR, Wilson SZ, Petrella R, Gilbert BE. Efficacy of high dose-short duration ribavirin aerosol in the treatment of respiratory syncytial virus infected cotton rats and influenza B virus infected mice. Antiviral Res. 1987 May; 7(4):211-20. PMID: 3304159.
      View in: PubMed
    83. Smith RH, Gilbert BE. Quantification of ribavirin in biological fluids and tissues by high-performance liquid chromatography. J Chromatogr. 1987 Feb 20; 414(1):202-10. PMID: 3571385.
      View in: PubMed
    84. Lewis DE, Gilbert BE, Knight V. Influenza virus infection induces functional alterations in peripheral blood lymphocytes. J Immunol. 1986 Dec 15; 137(12):3777-81. PMID: 2431043.
      View in: PubMed
    85. Wyde PR, Wilson SZ, Gilbert BE, Smith RH. Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol. Antimicrob Agents Chemother. 1986 Dec; 30(6):942-4. PMID: 3813516; PMCID: PMC180625.
    86. Gilbert BE, Knight V. Biochemistry and clinical applications of ribavirin. Antimicrob Agents Chemother. 1986 Aug; 30(2):201-5. PMID: 2876677; PMCID: PMC180518.
    87. Knight V, Gilbert BE. Chemotherapy of respiratory viruses. Adv Intern Med. 1986; 31:95-118. PMID: 2418643.
      View in: PubMed
    88. Wray SK, Smith RH, Gilbert BE, Knight V. Effects of selenazofurin and ribavirin and their 5'-triphosphates on replicative functions of influenza A and B viruses. Antimicrob Agents Chemother. 1986 Jan; 29(1):67-72. PMID: 3729336; PMCID: PMC180366.
    89. Gilbert BE, Wilson SZ, Knight V, Couch RB, Quarles JM, Dure L, Hayes N, Willis G. Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84. Antimicrob Agents Chemother. 1985 Mar; 27(3):309-13. PMID: 3888102; PMCID: PMC176267.
    90. Wray SK, Gilbert BE, Knight V. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Antiviral Res. 1985 Feb; 5(1):39-48. PMID: 3985607.
      View in: PubMed
    91. Wray SK, Gilbert BE, Noall MW, Knight V. Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. Antiviral Res. 1985 Feb; 5(1):29-37. PMID: 3985606.
      View in: PubMed
    92. Wilson SZ, Gilbert BE, Quarles JM, Knight V, McClung HW, Moore RV, Couch RB. Treatment of influenza A (H1N1) virus infection with ribavirin aerosol. Antimicrob Agents Chemother. 1984 Aug; 26(2):200-3. PMID: 6486761; PMCID: PMC284119.
    93. Taber LH, Knight V, Gilbert BE, McClung HW, Wilson SZ, Norton HJ, Thurson JM, Gordon WH, Atmar RL, Schlaudt WR. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics. 1983 Nov; 72(5):613-8. PMID: 6356005.
      View in: PubMed
    94. Wyde PR, Gilbert BE, Levy BM. Evidence that T-lymphocytes are part of the blood-brain barrier to virus dissemination. J Neuroimmunol. 1983 Aug; 5(1):47-58. PMID: 6603472.
      View in: PubMed
    95. McClung HW, Knight V, Gilbert BE, Wilson SZ, Quarles JM, Divine GW. Ribavirin aerosol treatment of influenza B virus infection. JAMA. 1983 May 20; 249(19):2671-4. PMID: 6341642.
      View in: PubMed
    96. McClung HW, Knight V, Gilbert BE, Wilson SZ, Quarles JM, Couch RB, Divine GW, Gordon WH, Thurston JM, Atmar RL, et al. Ribavirin aerosol treatment of influenza B virus infection. Trans Assoc Am Physicians. 1983; 96:284-93. PMID: 6093312.
      View in: PubMed
    GILBERT's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _